Psychopathology and symptoms of atrial fibrillation: Implications for therapy

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 5, 2012, Pages 473-478

  Gehi, Anil K ^a   Sears, Samuel ^b   Goli, Neeta ^c   Walker, T Jennifer ^a   Chung, Eugene ^a   Schwartz, Jennifer ^a   Wood, Kathryn A ^d   Guise, Kimberly ^a   Mounsey, J Paul ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c Eastern Virginia School of Medicine   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

anxiety; atrial fibrillation; depression; psychology; symptoms

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN;

ADULT; ANALYSIS OF COVARIANCE; ANXIETY; ARTICLE; CONFOUNDING VARIABLE; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUESTIONNAIRE; RATING SCALE; SHORT FORM 36; SOMATIZATION; SYMPTOM; TREATMENT INDICATION;

AGED; ANALYSIS OF VARIANCE; ANXIETY; ATRIAL FIBRILLATION; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 84860840489     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02264.x     Document Type: Article

References (30)

1. Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC,; RACE Study Group: Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 2004; 43: 241-247.
2. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A,: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1105.
3. Carnlof C, Insulander P, Pettersson PH, Jensen-Urstad M, Fossum B,: Health-related quality of life in patients with atrial fibrillation undergoing pulmonary vein isolation, before and after treatment. Eur J Cardiovasc Nurs 2010; 9: 45-49.
4. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology/American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354.
5. Dabrowski R, Smolis-Bak E, Kowalik I, Kazimierska B, Wojcicka M, Szwed H,: Quality of life and depression in patients with different patterns of atrial fibrillation. Kardiol Pol 2010; 68: 1133-1139.
6. Thrall G, Lip GY, Carroll D, Lane D,: Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest 2007; 132: 1259-1264.
7. Ong L, Cribbie R, Harris L, Dorian P, Newman D, Mangat I, Nolan R, Irvine J,: Psychological correlates of quality of life in atrial fibrillation. Qual Life Res 2006; 15: 1323-1333.
8. Ong L, Irvine J, Nolan R, Cribbie R, Harris L, Newman D, Mangat I, Dorian P,: Gender differences and quality of life in atrial fibrillation: The mediating role of depression. J Psychosom Res 2006; 61: 769-774.
9. Sears SF, Serber ER, Alvarez LG, Schwartzman DS, Hoyt RH, Ujhelyi MR,: Understanding atrial symptom reports: Objective versus subjective predictors. Pacing Clin Electrophysiol 2005; 28: 801-807.
10. Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino RB S, Benjamin EJ,: Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: The Framingham Offspring Study. Psychosom Med 2005; 67: 692-696.
11. Frasure-Smith N, Lesperance F, Habra M, Talajic M, Khairy P, Dorian P, Roy D,; Atrial Fibrillation and Congestive Heart Failure Investigators: Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 2009; 120: 134-140, 3p following 140.
12. Lange HW, Herrmann-Lingen C,: Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. J Psychosom Res 2007; 63: 509-513.
13. Tully PJ, Bennetts JS, Baker RA, McGavigan AD, Turnbull DA, Winefield HR,: Anxiety, depression, and stress as risk factors for atrial fibrillation after cardiac surgery. Heart Lung 2011; 40: 4-11.
14. Dorian P, Guerra PG, Kerr CR, O'Donnell SS, Crystal E, Gillis AM, Mitchell LB, Roy D, Skanes AC, Rose MS, Wyse DG,: Validation of a new simple scale to measure symptoms in atrial fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation scale. Circ Arrhythm Electrophysiol 2009; 2: 218-224.
15. Spertus J, Dorian P, Bubien R, Lewis S, Godejohn D, Reynolds MR, Lakkireddy DR, Wimmer AP, Bhandari A, Burk C,: Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol 2011; 4: 15-25.
16. Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J,: Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: The PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol 2000; 183: 759-769.
17. Kroenke K, Spitzer RL, Williams JB,: The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
18. Zigmond AS, Snaith RP,: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
19. Speckens AE, Spinhoven P, Sloekers PP, Bolk JH, van Hemert AM,: A validation study of the Whitely index, the illness attitude scales, and the somatosensory amplification scale in general medical and general practice patients. J Psychosom Res 1996; 40: 95-104.
20. Ware J Jr, Kosinski M, Keller SD,: A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
21. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, Camm J, Akhtar M, Luderitz B,: The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36: 1303-1309.
22. Spertus J, Dorian P, Bubien R, Lewis S, Godejohn D, Reynolds MR, Lakkireddy DR, Wimmer AP, Bhandari A, Burk C,: Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol 2011; 4: 15-25.
23. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I,: Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005; 111: 480-487.
24. Doering LV, Moser DK, Riegel B, McKinley S, Davidson P, Baker H, Meischke H, Dracup K,: Persistent comorbid symptoms of depression and anxiety predict mortality in heart disease. Int J Cardiol 2010; 145: 188-192.
25. Nicholson A, Kuper H, Hemingway H,: Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774.
26. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ,: Depression in heart failure: A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006; 48: 1527-1537.
27. Lane DA, Langman CM, Lip GY, Nouwen A,: Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. J Psychosom Res 2009; 66: 203-210.
28. Stewart JC, Janicki-Deverts D, Muldoon MF, Kamarck TW,: Depressive symptoms moderate the influence of hostility on serum interleukin-6 and C-reactive protein. Psychosom Med 2008; 70: 197-204.
29. Carney RM, Freedland KE, Veith RC,: Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005; 67 (Suppl 1): S29-S33.
30. Wood KA, Wiener CL, Kayser-Jones J,: Supraventricular tachycardia and the struggle to be believed. Eur J Cardiovasc Nurs 2007; 6: 293-302.